image
Healthcare - Biotechnology - NASDAQ - US
$ 0.99
-5.71 %
$ 75.1 M
Market Cap
-2.02
P/E
BALANCE SHEET
34 M ASSETS
-33.69%
49.9 M LIABILITIES
22.69%
-15.9 M EQUITY
-150.01%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Clearside Biomedical, Inc.
image
Current Assets 30.1 M
Cash & Short-Term Investments 28.9 M
Receivables 170 K
Other Current Assets 1.03 M
Non-Current Assets 3.9 M
Long-Term Investments 0
PP&E 3.86 M
Other Non-Current Assets 30 K
Current Liabilities 6.81 M
Accounts Payable 2.2 M
Short-Term Debt 728 K
Other Current Liabilities 3.88 M
Non-Current Liabilities 43.1 M
Long-Term Debt 42.6 M
Other Non-Current Liabilities 480 K

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
ASSETS
Cash & Cash Equivalents 28.9 48.3 30.4 17.3 22.6 8.0 9.2 34.8 20.3 8.3 1.9 0.9
Short Term Investments 0 0 0 0 0 32.8 28.4 48.8 0 0 0 0
Receivables 0.2 0 10.0 0 0 0 0 0 0 0 0 0
Inventory 0 0 0.9 0 0 0 0 0 0 0 0 0
Other Current Assets 1.0 1.1 1.7 0.8 2.6 2.1 1.6 0.7 0.2 54 K 0.1 27 K
Total Current Assets 30.1 48.3 42.1 18.1 25.2 42.9 37.6 83.6 20.5 8.3 2.0 0.9
PP&E 3.9 1.9 0.6 0.9 1.2 0.8 0.9 94 K 0.2 0.2 98 K 50 K
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 30 K 0.2 0.3 0.4 0.4 0.4 0.4 0 0 0 0
Other Long Term Assets 30 K 1.1 0 0 0 26 K (0.9) 94 K 0.4 1.8 22 K 50 K
Other Assets 0 0 0 0 0 0 2.5 0.8 0 0 0 15 K
Total Assets 34.0 51.3 42.9 19.3 26.8 44.1 40.5 84.8 21.1 10.3 2.1 0.9
LIABILITIES
Accounts Payable 2.2 1.1 0.9 2.0 1.3 6.9 5.4 2.6 1.5 1.3 0.2 0
Short Term Debt 0.7 0.7 0.8 1.7 2.1 0.6 3.2 0 1.7 0 0 0
Other Current Liabilities 3.8 3.8 2.9 1.2 2.6 3.1 4.9 2.8 2.0 1.2 0.4 0.5
Total Current Liabilities 6.8 5.8 4.6 9.9 10.9 10.5 13.5 5.4 5.2 2.4 0.7 0.5
Long Term Debt 42.6 0.9 0.3 0.6 4.7 9.4 4.8 7.6 4.2 0 0.3 0.1
Deferred Tax Income 0 0 0 0 0 0 (0.8) (0.3) 47.3 0 0 0
Other Liabilities 0.5 34.0 0 0 0 0.6 0.6 0 0.3 26.9 11.9 0
Total Liabilities 49.9 40.7 4.9 10.6 15.6 20.5 19.1 13.2 57.7 29.5 12.9 0.7
EQUITY
Common Stock 63 K 61 K 60 K 52 K 44 K 32 K 25 K 25 K 3 K 4 K 3 K 2 K
Retained Earnings (320.9) (288.4) (255.5) (255.9) (237.7) (206.9) (124.2) (65.2) (39.4) (21.7) (11.5) (4.3)
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 0 8 K 13 K (0.1) 55 K 22 K 0
Total Equity (15.9) 10.6 38.0 8.8 11.2 23.6 21.4 71.7 (36.7) (19.2) (10.7) 0.2
Total Liabilities and Equity 34.0 51.3 42.9 19.3 26.8 44.1 40.5 84.8 21.1 10.3 2.1 0
SHARES OUTSTANDING
Common Shares Outstanding 61.8 60.2 58.5 46.5 38.2 30.7 25.3 13.1 12.3 12.3 12.3 0.8